“They’re Winning”: How the Mifepristone Case Could Sabotage the FDA

A Trump-appointed judge’s ruling against the abortion pill may be “a Mad Lib of a legal opinion,” but that doesn’t mean it couldn’t succeed in radically restricting reproductive rights and gutting the federal government’s ability to safeguard the nation’s drug supply.

Read more at Vanity Fair